基本信息
views: 16
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Habib Yaribeygi currently works at the Research Center of Physiology , Semnan University of Medical Sciences (Semnan/Iran). Habib does research in Physiology, Nephrology and Medical Science Nursing. His current projects are:
1. 'Effects of Crocin & Fenofibrate on the Renal Functions and expression of Interleukin-18 and NADPH Oxidase-4 in experimental model of Diabetic Nephropathy'.
2. Diabetes and Oxidative Stress
3. Possible Anti oxidative Effects of Crocin in Vary Tissues
4. Diabetes and Ceramide
5. SGLT2 inhibitors and Diabetes
6. SGLT2 Inhibitors and Oxidative Stress
7. Diabetes and Micro RNA
8. Micro RNA and Oxidative Stress
9. Nlrp3 Inflammasome and Inflammatory responses in Kidneys
Research Interests
Papers共 116 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2024): 100340-100340
Habib Yaribeygi,Mina Maleki,Farin Rashid-Farrokhi, Payman Raise Abdullahi, Mohammad Amin Hemmati,Tannaz Jamialahmadi,Amirhossein Sahebkar
Habib Yaribeygi, Mohammad Amin Hemmati,Fatemeh Nasimi,Roghayeh Pakdel,Tannaz Jamialahmadi,Amirhossein Sahebkar
BEHAVIOURAL BRAIN RESEARCH (2024): 114830-114830
Current diabetes reviews (2024)
Habib Yaribeygi,Mina Maleki,Tannaz Jamialahmadi, Nikolay K. Shakhpazyan,Prashant Kesharwani,Amirhossein Sahebkar
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWSno. 10 (2023): 102869-102869
EXCLI Journal : Experimental and Clinical Sciences (2023): 53-66
Current medicinal chemistry (2023)
Current Medicinal Chemistryno. 37 (2023): 4256-4265
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn